Fei Xu

机构：Shanghai Medical College of Fudan University, Sun Yat-sen University, Chongqing University, Sichuan University, Fudan University Shanghai Cancer Center, First Affiliated Hospital of Jiangxi Medical College, Chengdu University, Sun Yat-sen University Cancer Center, Heilongjiang Institute of Technology · ORCID：0000-0002-5572-5338

发表论文 79 篇 · 总被引 1151 次 · h-index 16

代表论文

• Microbial metabolite enhances immunotherapy efficacy by modulating T cell stemness in pan-cancer (2024 · Cell · 被引 423)
• The mechanism of PFK-1 in the occurrence and development of bladder cancer by regulating ZEB1 lactylation (2024 · BMC Urology · 被引 32)
• Influence of PD‐L1 expression on the efficacy of EGFR ‐TKIs in EGFR ‐mutant non‐small cell lung cancer (2023 · Thoracic Cancer · 被引 13)
• Comprehensive analysis of the relationship between ubiquitin-specific protease 21 (USP21) and prognosis, tumor microenvironment infiltration, and therapy response in colorectal cancer (2024 · Cancer Immunology Immunotherapy · 被引 8)
• Organ-specific immune checkpoint inhibitor treatment in lung cancer: a systematic review and meta-analysis (2023 · BMJ Open · 被引 7)
• Coronary endarterectomy combined with coronary artery bypass grafting might decrease graft patency: A cohort study (2023 · Hellenic Journal of Cardiology · 被引 5)